Skip to main content
Livermore
Livermore
ZHEN

Parallel Advisors, LLC

SEC CIK
0001690010
Latest filing
Aug 5, 2026

RDY holding history

Dr Reddys Laboratories Ltd in every 13F filed by Parallel Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RDY overviewAll 13F holders of RDYFull Q2 2026 holdings

Shares (Q2 2026)
81,864
Value
$1.19M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of RDY by Parallel Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202681,864$1.19M<0.1%−6,309−7.2%ReducedHolders
Q1 202688,173$1.22M<0.1%+22,331+33.9%AddedHolders
Q4 202565,842$924.4K<0.1%−12,858−16.3%ReducedHolders
Q3 202578,700$1.10M<0.1%+260+0.3%AddedHolders
Q2 202578,440$1.18M<0.1%+29,375+59.9%AddedHolders
Q1 202549,065$647.2K<0.1%−23,725−32.6%ReducedHolders
Q4 202472,790$1.15M<0.1%00.0%UnchangedConverted for a 5-for-1 splitHolders
Q3 202414,572$1.16M<0.1%+2,150+17.3%AddedHolders
Q2 202412,422$946.4K<0.1%+1,470+13.4%AddedHolders
Q1 202410,952$803.3K<0.1%+4,438+68.1%AddedHolders
Q4 20236,514$453.2K<0.1%+377+6.1%AddedHolders
Q3 20236,137$410.4K<0.1%+1,723+39.0%AddedHolders
Q2 20234,414$278.6K<0.1%+205+4.9%AddedHolders
Q1 20234,209$239.6K<0.1%+1,144+37.3%AddedHolders
Q4 20223,065$158.6K<0.1%−2,486−44.8%ReducedHolders
Q3 20225,551$291.0K<0.1%+1,055+23.5%AddedHolders
Q2 20224,496$249.0K<0.1%+618+15.9%AddedHolders
Q1 20223,878$220.0K<0.1%+294+8.2%AddedHolders
Q4 20213,584$234.0K<0.1%−250−6.5%ReducedHolders
Q3 20213,834$250.0K<0.1%+57+1.5%AddedHolders
Q2 20213,777$278.0K<0.1%+200+5.6%AddedHolders
Q1 20213,577$220.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.